However, the company developed its competitive edge with the Trikafta treatment getting approved ... Vertex Pharmaceuticals ...
But when something this big happens with VRTX, it often means somebody knows ... Smart Money on the Move Benzinga Edge's Unusual Options board spots potential market movers before they happen.
View Vertex Pharmaceuticals Incorporated (VRTX) current and estimated P/E ratio data provided by Seeking Alpha.
Vertex Pharmaceuticals (VRTX) closed at $469.29 in the latest trading session, marking a -0.99% move from the prior day. The stock's change was less than the S&P 500's daily loss of 0.3%.
Price Action: VRTX stock is up 2.16% at $472.06 at last check Monday. UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and ...
Price Action: VRTX stock is down 13.4% at $387.37 at last check Thursday. UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is a global leader in cystic ... However, the company developed its competitive edge with the Trikafta treatment getting approved in 2019.